86 related articles for article (PubMed ID: 6334123)
1. [In vitro cytotoxicity of methotrexate].
Maehara S
Nihon Seikeigeka Gakkai Zasshi; 1984 Jul; 58(7):677-84. PubMed ID: 6334123
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the effect of high-dose methotrexate-citrovorum factor treatment for 89Sr induced osteosarcoma in mice (author's transl)].
Nakamura T
Nihon Seikeigeka Gakkai Zasshi; 1982 Feb; 56(2):149-61. PubMed ID: 6978919
[TBL] [Abstract][Full Text] [Related]
3. Effect of methotrexate on murine bone marrow cells in vitro: evidence of a reversible antiproliferative action.
Strømhaug A; Warren DJ; Slørdal L
Exp Hematol; 1995 May; 23(5):439-43. PubMed ID: 7720815
[TBL] [Abstract][Full Text] [Related]
4. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
Pinedo HM; Zaharko DS; Bull JM; Chabner BA
Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
[TBL] [Abstract][Full Text] [Related]
5. Isolation of tumor cells from patients with osteosarcoma and analysis of their sensitivity to methotrexate.
Mordoh J; Chacón RD; Filmus J
Cancer Res; 1981 Sep; 41(9 Pt 1):3621-8. PubMed ID: 6942915
[TBL] [Abstract][Full Text] [Related]
6. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
Sirotnak FM; Otter GM; Schmid FA
Cancer Res; 1993 Feb; 53(3):587-91. PubMed ID: 8425192
[TBL] [Abstract][Full Text] [Related]
7. [Cell cycles of cancer cells and chemotherapy--flow cytometric observation of the effects of chemotherapeutic agents on cell kinetics of cultured human lung cancer cells].
Shimizu T
Hokkaido Igaku Zasshi; 1983 Sep; 58(5):467-82. PubMed ID: 6662482
[TBL] [Abstract][Full Text] [Related]
8. Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells.
De Soto JA; Bowen D; Davis JH; Southerland WM; Hawkins M
Anticancer Res; 2002; 22(2A):1007-9. PubMed ID: 12014617
[TBL] [Abstract][Full Text] [Related]
9. [The effect of CdCl2 and ZnCl2 on Dunn osteosarcoma].
Noda K
Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):70-5. PubMed ID: 2319195
[TBL] [Abstract][Full Text] [Related]
10. [Tissue concentration of methotrexate in osteosarcoma after high-dose infusion].
Amino K
Nihon Seikeigeka Gakkai Zasshi; 1982 Aug; 56(8):765-76. PubMed ID: 6984057
[TBL] [Abstract][Full Text] [Related]
11. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
Samuels LL; Straw JA
Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
[TBL] [Abstract][Full Text] [Related]
12. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
Chu BC; Whiteley JM
J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase as a target for growth inhibition in methotrexate-sensitive and -resistant human head and neck cancer and leukemia cell lines.
McGuire JJ; Magee KJ; Russell CA; Canestrari JM
Oncol Res; 1997; 9(3):139-47. PubMed ID: 9220499
[TBL] [Abstract][Full Text] [Related]
14. Resistance of resting 3T6 mouse fibroblasts to methotrexate cytotoxicity.
Johnson LF; Fuhrman CL; Abelson HT
Cancer Res; 1978 Aug; 38(8):2408-12. PubMed ID: 667839
[TBL] [Abstract][Full Text] [Related]
15. [Effect of rescue treatment with high doses of methotrexate (MTX) followed by leucovorin (LV) on neoplastic cells (HeLa line) and normal sensitized peripheral lymphocytes].
Ruano A; Alvarez-Rodríguez Y; Valladares Y
Rev Esp Oncol; 1982; 29(4):665-73. PubMed ID: 6985426
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
Maca RD
Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
[TBL] [Abstract][Full Text] [Related]
17. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
Bures L; Motycka K; Bostík J; Slavík K; Jirásek A
Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803
[TBL] [Abstract][Full Text] [Related]
18. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
19. [Enhancement of tumor-specific killer T cell activities by high-dose methotrexate].
Chigira M
Nihon Seikeigeka Gakkai Zasshi; 1983 May; 57(5):533-8. PubMed ID: 6224870
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.
Fabre I; Fabre G; Goldman ID
Cancer Res; 1984 Aug; 44(8):3190-5. PubMed ID: 6204743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
